EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Intravenous Iron Therapy in Patients with Iron Deficiency Anemia: Dosing Considerations

Todd A Koch, Jennifer Myers, Lawrence Tim Goodnough

Anemia · 2015 · 2015 · 1-10

DOI: 10.1155/2015/763576 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anemia, 2015. Verfasst von Todd A Koch und 2 weiteren Autor:innen. Beteiligte Einrichtung: Luitpold Pharmaceuticals, Inc., Norristown, PA 19403, USA. Die Arbeit wurde bisher 88-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To provide clinicians with evidence-based guidance for iron therapy dosing in patients with iron deficiency anemia (IDA), we conducted a study examining the benefits of a higher cumulative dose of intravenous (IV) iron than what is typically administered.

Methods

We first individually analyzed 5 clinical studies, averaging the total iron deficit across all patients utilizing a modified Ganzoni formula; we then similarly analyzed 2 larger clinical studies. For the second of the larger studies (Study 7), we also compared the efficacy and retreatment requirements of a cumulative dose of 1500 mg ferric carboxymaltose (FCM) to 1000 mg iron sucrose (IS).

Results

The average iron deficit was calculated to be 1531 mg for patients in Studies 1–5 and 1392 mg for patients in Studies 6-7. The percentage of patients who were retreated with IV iron between Days 56 and 90 was significantly ( p < 0.001 ) lower (5.6%) in the 1500 mg group, compared to the 1000 mg group (11.1%).

Conclusions

Our data suggests that a total cumulative dose of 1000 mg of IV iron may be insufficient for iron repletion in a majority of patients with IDA and a dose of 1500 mg is closer to the actual iron deficit in these patients.

Autor:innen und Institutionen

  • Luitpold Pharmaceuticals, Inc., Norristown, PA 19403, USA.
  • St. John's University, Jamaica, NY 11439, USA.
  • Department of Pathology and Medicine (Hematology), Stanford, CA 94305, USA.

Zitieren

APA

Koch, T. A., Myers, J., & Goodnough, L. T. (2015). Intravenous Iron Therapy in Patients with Iron Deficiency Anemia: Dosing Considerations. Anemia, 2015, 1-10. https://doi.org/10.1155/2015/763576

Vancouver

Koch TA, Myers J, Goodnough LT. Intravenous Iron Therapy in Patients with Iron Deficiency Anemia: Dosing Considerations. Anemia. 2015;2015:1-10. doi:10.1155/2015/763576

BibTeX
@article{Koch2015,
  author = {Koch, Todd A and Myers, Jennifer and Goodnough, Lawrence Tim},
  title = {Intravenous Iron Therapy in Patients with Iron Deficiency Anemia: Dosing Considerations},
  journal = {Anemia},
  year = {2015},
  volume = {2015},
  pages = {1--10},
  doi = {10.1155/2015/763576}
}
Kostenlos starten →